Sewoon Medical Co., Ltd (KOSDAQ:100700)
South Korea · Delayed Price · Currency is KRW 2,560.00
-20.00 (-0.78%)
At close: Sep 17, 2025
Sewoon Medical Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | 10,134 | 12,163 | 14,957 | 10,406 | 12,282 | 10,496 | Upgrade |
Depreciation & Amortization | 3,446 | 3,480 | 3,648 | 3,888 | 3,836 | 3,684 | Upgrade |
Loss (Gain) From Sale of Assets | -288.46 | -279.54 | -17.79 | -2.2 | 0.67 | 8.81 | Upgrade |
Asset Writedown & Restructuring Costs | -0.78 | - | -1.22 | 2 | -7.63 | 226.83 | Upgrade |
Provision & Write-off of Bad Debts | -0.85 | 7.31 | -1.25 | -15.31 | -22.77 | -44.31 | Upgrade |
Other Operating Activities | 581.95 | -2,201 | 2,807 | -1,861 | 2,413 | 2,179 | Upgrade |
Change in Accounts Receivable | 317.18 | 620.44 | 372.12 | -1,150 | 1,672 | 2,236 | Upgrade |
Change in Inventory | -434.82 | -1,268 | 203.91 | -1,177 | 2,077 | -508.68 | Upgrade |
Change in Accounts Payable | 323.75 | -356.95 | -92.73 | -418.94 | -271.82 | 492.94 | Upgrade |
Change in Other Net Operating Assets | 409.07 | 1,021 | 1,201 | -393.25 | -508.66 | 481.34 | Upgrade |
Operating Cash Flow | 14,487 | 13,186 | 23,076 | 9,279 | 21,469 | 19,252 | Upgrade |
Operating Cash Flow Growth | -14.06% | -42.86% | 148.71% | -56.78% | 11.52% | 42.81% | Upgrade |
Capital Expenditures | -1,690 | -1,435 | -1,949 | -2,151 | -2,224 | -2,274 | Upgrade |
Sale of Property, Plant & Equipment | 1,080 | 1,127 | 609.45 | 369.82 | 296.88 | 331.32 | Upgrade |
Divestitures | - | - | - | - | - | 776.67 | Upgrade |
Sale (Purchase) of Intangibles | -216.41 | -216.2 | -6.59 | -17.12 | -265.02 | -1,214 | Upgrade |
Investment in Securities | -15,000 | 87.8 | 24,989 | -18,010 | -6,986 | 45.37 | Upgrade |
Other Investing Activities | 54 | 87.3 | 0.27 | -12.84 | 2 | -195.55 | Upgrade |
Investing Cash Flow | -15,773 | -349.15 | 23,642 | -19,821 | -9,177 | -2,530 | Upgrade |
Long-Term Debt Repaid | - | -254.62 | -295.87 | -297.92 | -275.49 | -151.81 | Upgrade |
Total Debt Repaid | -250.12 | -254.62 | -295.87 | -297.92 | -275.49 | -151.81 | Upgrade |
Net Debt Issued (Repaid) | -250.12 | -254.62 | -295.87 | -297.92 | -275.49 | -151.81 | Upgrade |
Dividends Paid | -2,597 | -3,030 | -2,597 | -2,165 | -2,165 | -2,165 | Upgrade |
Financing Cash Flow | -3,550 | -3,285 | -2,893 | -2,462 | -2,440 | -2,316 | Upgrade |
Foreign Exchange Rate Adjustments | -263.47 | 836.78 | -118.43 | 156.3 | 361.33 | -112.19 | Upgrade |
Miscellaneous Cash Flow Adjustments | 0 | - | - | - | - | - | Upgrade |
Net Cash Flow | -5,100 | 10,388 | 43,707 | -12,849 | 10,213 | 14,293 | Upgrade |
Free Cash Flow | 12,797 | 11,750 | 21,127 | 7,128 | 19,244 | 16,978 | Upgrade |
Free Cash Flow Growth | -15.51% | -44.38% | 196.41% | -62.96% | 13.35% | 124.98% | Upgrade |
Free Cash Flow Margin | 21.23% | 19.54% | 30.96% | 11.86% | 30.75% | 26.64% | Upgrade |
Free Cash Flow Per Share | 295.60 | 271.42 | 488.02 | 164.65 | 444.53 | 392.19 | Upgrade |
Cash Interest Paid | 40.79 | 36.63 | - | - | - | 31.63 | Upgrade |
Cash Income Tax Paid | 3,082 | 4,696 | 2,360 | 4,920 | 1,410 | 3,709 | Upgrade |
Levered Free Cash Flow | 8,932 | 6,444 | 16,336 | 4,115 | 16,161 | 13,411 | Upgrade |
Unlevered Free Cash Flow | 8,958 | 6,467 | 16,358 | 4,137 | 16,180 | 13,431 | Upgrade |
Change in Working Capital | 615.17 | 16.18 | 1,685 | -3,139 | 2,968 | 2,701 | Upgrade |
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.